An epidemiological assessment of health status among a cohort of tuberculosis survivors: prospective research in a western Indian city

Submitted: July 31, 2024
Accepted: November 4, 2024
Published: January 10, 2025
Abstract Views: 0
PDF_EARLY VIEW: 0
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Long-term follow-up of tuberculosis (TB) is important to monitor treatment outcomes, prevent relapse, and improve patient care. The aims of the current study are: i) to assess various epidemiological parameters among TB survivors, like mortality and morbidity, with emphasis on recurrence status during pre-defined long-term follow-up; ii) to assess factors responsible for the recurrence of TB among study participants. A prospective observational study was conducted among cured cases of pulmonary TB registered at the TB unit of Ahmedabad City, India. As per the calculated sample size, 180 study participants were recruited by systematic random sampling from a list of cured TB cases from July to September 2021. Follow-ups of participants were conducted at 6, 12, 18, and 24 months post-recruitment. The status of cured cases was assessed by a pre-validated questionnaire. Factors significantly associated with the likelihood of TB were analyzed using logistic regression. Of the total 180 cured TB cases, 22 (12.2%) developed recurrent TB, and 12 (6.6%) deaths were recorded during the entire follow-up duration of 2 years. Among the cases assessed, 106 (71.6%) were found to be asymptomatic in the context of TB at 2 years post-treatment completion. Around 17 (77.2%) recurrent cases were diagnosed within a year of treatment completion. Factors significantly associated with recurrence were age (p=0.01), body mass index (p=0.02), and socio-economic status (p=0.03) of the study population. Overall recurrence assessed during 2 years of post-treatment follow-up among the cohort of TB survivors was 12.2%. As per the study findings, socio-demographic and nutritional factors play a significant role in the development of recurrent TB, highlighting the importance of targeted interventions.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

WHO. Tuberculosis. 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/tuberculosis. Accessed on: 10/04/2024.
Millet JP, Shaw E, Orcau A, et al. Tuberculosis recurrence after completion treatment in a european city: reinfection or relapse? PLoS One 2013;8:e64898. DOI: https://doi.org/10.1371/journal.pone.0064898
Sadacharam K, Gopi PG, Chandrasekaran V, et al. Status of smear-positive TB patients at 2-3 years after initiation of treatment under a DOTS programme. Indian J Tuberc 2007;54:199-203.
Azhar GS. DOTS for TB relapse in India: a systematic review. Lung India 2012;29:147-53. DOI: https://doi.org/10.4103/0970-2113.95320
Dave P, Rade K, Modi B, et al. assessment of long-term outcome among new smear positive pulmonary TB patients treated with intermittent regimen under RNTCP – a retrospective cohort study. Natl J Community Med 2013;4:189-94.
National Tuberculosis Elimination Pogramme. Long term post-treatment follow up of TB patients. Available from: https://ntep.in/node/611/CP-long-term-post-treatment-follow-tb-patients. Accessed on: 10/04/2024.
Ahmedabad District, Government of Gujarat. History. Available from: https://ahmedabad.nic.in/history/. Accessed on: 10/04/2024.
Pourhoseingholi MA, Vahedi M, Rahimzadeh M. Sample size calculation in medical studies. Gastroenterol Hepatol Bed Bench 2013;6:14-7.
Lambert M, Hasker E, Deun A, et al. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003;3:282-7. DOI: https://doi.org/10.1016/S1473-3099(03)00607-8
Giridharan P, Selvaraju S, Rao R, et al. Recurrence of pulmonary tuberculosis in India: Findings from the 2019-2021 nationwide community-based TB prevalence survey. PLoS One 2023;18:e0294254. DOI: https://doi.org/10.1371/journal.pone.0294254
Anaam MS, Alrasheedy AA. Recurrence rate of pulmonary tuberculosis in patients treated with the standard 6-month regimen: findings and implications from a prospective observational multicenter study. Trop Med Infect Dis 2023;8:110. DOI: https://doi.org/10.3390/tropicalmed8020110
Mathur N, Chatla C, Syed S, et al. Prospective 1-year follow-up study of all cured, new sputum smear positive tuberculosis patients under the Revised National Tuberculosis Control Program in Hyderabad, Telangana State, India. Lung India 2019;36:519-24. DOI: https://doi.org/10.4103/lungindia.lungindia_143_19
Agarwal AK, Aharwal D, Verma R, et al. Observation study among cured cases of pulmonary tuberculosis: a long-term study under the revised national tuberculosis control program. J Epidemiol Public Health 2023;8:223-32. DOI: https://doi.org/10.26911/jepublichealth.2023.08.02.07
Thomas A, Gopi PG, Santha T, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005;9:556-61.
Joseph MR, Thomas RA, Nair S, et al. Directly observed treatment short course for tuberculosis. What happens to them in the long term? Indian J Tuberc 2015;62:29-35. DOI: https://doi.org/10.1016/j.ijtb.2015.02.005
Sharma R, Prajapati S, Patel P, et al. An outcome-based follow-up study of cured category I pulmonary tuberculosis adult cases from various tuberculosis units under revised national tuberculosis control program from a western Indian city. Indian J Community Med 2019;44:48-52. DOI: https://doi.org/10.4103/ijcm.IJCM_310_18
Bobokhojaev OI. Long-term results of 10 years of observation of cured cases of pulmonary tuberculosis. J Pulmonol Respir Res 2022;6:007-011. DOI: https://doi.org/10.29328/journal.jprr.1001036
Verma SK, Kant S, Kumar S, Prasad R. A five-year follow-up study of revised national tuberculosis control programme of India at Lucknow Indian J Chest Dis Allied Sci 2008;50:195-7.

Ethics Approval

This research has been ethically approved by Institutional ethics committee (No. GCSMC/EC/Research Project/ APPROVE/2021/319 Dated 3 August 2021).

How to Cite

Shah, Venu, Viral Dave, Vaidehi Gohil, and Hardika Khanpara. 2025. “An Epidemiological Assessment of Health Status Among a Cohort of Tuberculosis Survivors: Prospective Research in a Western Indian City”. Monaldi Archives for Chest Disease, January. https://doi.org/10.4081/monaldi.2025.3163.

Similar Articles

<< < 49 50 51 52 53 54 55 > >> 

You may also start an advanced similarity search for this article.